BACKGROUND: Sodium bicarbonate (NaHCO3) is a common treatment for metabolic acidemia; however, little definitive information exists regarding its treatment efficacy and cerebral hemodynamic effects. This pilot observational study quantifies relative changes in cerebral blood flow (ΔrCBF) and oxy- and deoxyhemoglobin concentrations (ΔHbO2 and ΔHb) due to bolus administration of NaHCO3 in patients with mild base deficits. METHODS: Infants and children with hypoplastic left heart syndrome (HLHS) were enrolled before cardiac surgery. NaHCO3 was given as needed for treatment of base deficit. Diffuse optical spectroscopies were used for 15 min postinjection to noninvasively monitor ΔHb, ΔHbO2, and ΔrCBF relative to baseline before NaHCO3 administration. RESULTS: Twenty-two anesthetized and mechanically ventilated patients with HLHS (aged 1 d to 4 y) received a median (interquartile range) dose of 1.1 (0.8, 1.8) mEq/kg NaHCO3 administered intravenously over 10-20 s to treat a median (interquartile range) base deficit of -4 (-6, -3) mEq/l. NaHCO3 caused significant dose-dependent increases in ΔrCBF; however, population-averaged ΔHb and ΔHbO2 as compared with those of controls were not significant. CONCLUSIONS: Dose-dependent increases in cerebral blood flow (CBF) caused by bolus administration of NaHCO3 are an important consideration in vulnerable populations wherein risk of rapid CBF fluctuations does not outweigh the benefit of treating a base deficit.
BACKGROUND:Sodium bicarbonate (NaHCO3) is a common treatment for metabolic acidemia; however, little definitive information exists regarding its treatment efficacy and cerebral hemodynamic effects. This pilot observational study quantifies relative changes in cerebral blood flow (ΔrCBF) and oxy- and deoxyhemoglobin concentrations (ΔHbO2 and ΔHb) due to bolus administration of NaHCO3 in patients with mild base deficits. METHODS:Infants and children with hypoplastic left heart syndrome (HLHS) were enrolled before cardiac surgery. NaHCO3 was given as needed for treatment of base deficit. Diffuse optical spectroscopies were used for 15 min postinjection to noninvasively monitor ΔHb, ΔHbO2, and ΔrCBF relative to baseline before NaHCO3 administration. RESULTS: Twenty-two anesthetized and mechanically ventilated patients with HLHS (aged 1 d to 4 y) received a median (interquartile range) dose of 1.1 (0.8, 1.8) mEq/kg NaHCO3 administered intravenously over 10-20 s to treat a median (interquartile range) base deficit of -4 (-6, -3) mEq/l. NaHCO3 caused significant dose-dependent increases in ΔrCBF; however, population-averaged ΔHb and ΔHbO2 as compared with those of controls were not significant. CONCLUSIONS: Dose-dependent increases in cerebral blood flow (CBF) caused by bolus administration of NaHCO3 are an important consideration in vulnerable populations wherein risk of rapid CBF fluctuations does not outweigh the benefit of treating a base deficit.
Authors: Chao Zhou; Stephanie A Eucker; Turgut Durduran; Guoqiang Yu; Jill Ralston; Stuart H Friess; Rebecca N Ichord; Susan S Margulies; Arjun G Yodh Journal: J Biomed Opt Date: 2009 May-Jun Impact factor: 3.170
Authors: Erin M Buckley; Ashwin B Parthasarathy; P Ellen Grant; Arjun G Yodh; Maria Angela Franceschini Journal: Neurophotonics Date: 2014-06-20 Impact factor: 3.593
Authors: Jennifer M Lynch; Erin M Buckley; Peter J Schwab; Ann L McCarthy; Madeline E Winters; David R Busch; Rui Xiao; Donna A Goff; Susan C Nicolson; Lisa M Montenegro; Stephanie Fuller; J William Gaynor; Thomas L Spray; Arjun G Yodh; Maryam Y Naim; Daniel J Licht Journal: J Thorac Cardiovasc Surg Date: 2014-06-27 Impact factor: 5.209
Authors: Parisa Farzam; Erin M Buckley; Pei-Yi Lin; Katherine Hagan; P Ellen Grant; Terrie Eleanor Inder; Stefan A Carp; Maria Angela Franceschini Journal: Sci Rep Date: 2017-11-17 Impact factor: 4.379